Atlas H&E-TME: Scalable AI-Based Tissue Profiling at Expert Pathologist-Level Accuracy
- URL: http://arxiv.org/abs/2606.12346v1
- Date: Wed, 10 Jun 2026 17:17:52 GMT
- Title: Atlas H&E-TME: Scalable AI-Based Tissue Profiling at Expert Pathologist-Level Accuracy
- Abstract summary: Hematoxylin and eosin staining is the cornerstone of histopathology.<n>We present Atlas H&E-TME, an AI-based system built on the Atlas family of pathology foundation models.
- Score: 31.3435140519617
- License: http://creativecommons.org/licenses/by-nc-nd/4.0/
- Abstract: Hematoxylin and eosin (H&E) staining is the cornerstone of histopathology, yet scalable, quantitative analysis of H&E whole-slide images (WSIs) remains a central challenge in computational pathology. We present Atlas H&E-TME, an AI-based system built on the Atlas family of pathology foundation models that predicts tissue quality, tissue region, and cell type labels across multiple cancer types, yielding over 4,500 quantitative readouts per slide at cell-level resolution. A key challenge to validating such systems is overcoming morphological ambiguity inherent to H&E-only ground truth and the limited scalability of more informed references drawing on modalities such as immunohistochemistry (IHC). We address this with a dual validation framework combining biologically grounded depth with technical and morphological breadth. For depth, we propose an IHC-informed multi-pathologist consensus protocol that substantially improves inter-rater agreement over conventional H&E-only annotation. This yields a molecularly grounded reference against which we compare Atlas H&E-TME and pathologists working from H&E alone. For breadth, we benchmark Atlas H&E-TME on over 200,000 high-confidence H&E-only pathologist annotations across 1,500+ cases spanning eight cancer types and their most common metastatic sites, with subtypes covering >90% of clinical cases per cancer type, drawn from 25+ sources and 8+ scanner models. Benchmarked against the IHC-informed consensus, Atlas H&E-TME matches or exceeds pathologist H&E-only performance and generalizes consistently and robustly across this broad morphological and technical scope. In doing so, Atlas H&E-TME turns the H&E slide -- the most ubiquitous data in pathology -- into a scalable, quantitative window into the tumor and its microenvironment, laying a foundation for the next generation of tissue-based biomarkers in translational and clinical research.
Related papers
- Towards Reliable Stain Transfer: An Iterative Data-Model Co-Optimization Framework Based on Multimodal Expert-Guided Assessment [55.16957949238588]
We propose DMCoStain, a novel Data-Model Co-optimization framework for Stain transfer.<n>It iteratively co-refines training data and model capability, improving staining accuracy and interpretability in both pathological and structural consistency.<n>To support MEGFS, we construct ImmunoInstruction, the first large-scale IPE instruction-following dataset with 150K VQA samples.
arXiv Detail & Related papers (2026-07-28T07:54:43Z) - Dictionary-based Pathology Mining with Hard-instance-assisted Classifier Debiasing for Genetic Biomarker Prediction from WSIs [20.737672401155603]
Prediction of genetic biomarkers in colorectal cancer is crucial for clinical decision making.<n>But, two primary challenges hamper accurate prediction: (1) It is difficult to construct a pathology-aware representation involving the complex interconnections among pathological components.<n>We hereby propose a Dictionary-based hierarchical pathology mining with hard-instance-assisted classifier Debiasing framework to address these challenges, dubbed as D2Bio.
arXiv Detail & Related papers (2026-03-26T14:23:28Z) - A Multicentric Dataset for Training and Benchmarking Breast Cancer Segmentation in H&E Slides [1.2783652545738993]
We introduce BrEast cancEr hisTopathoLogy sEgmentation (BEETLE), a dataset for multiclass semantic segmentation of H&E-stained breast cancer WSIs.<n>It consists of 587 biopsies and resections from three collaborating clinical centers and two public datasets, digitized using seven scanners, and covers all molecular subtypes and histological grades.<n>The dataset's diversity and relevance to the rapidly growing field of automated biomarker quantification in breast cancer ensure its high potential for reuse.
arXiv Detail & Related papers (2025-10-02T14:09:21Z) - A Knowledge-enhanced Pathology Vision-language Foundation Model for Cancer Diagnosis [58.85247337449624]
We propose a knowledge-enhanced vision-language pre-training approach that integrates disease knowledge into the alignment within hierarchical semantic groups.<n>KEEP achieves state-of-the-art performance in zero-shot cancer diagnostic tasks.
arXiv Detail & Related papers (2024-12-17T17:45:21Z) - Towards a Comprehensive Benchmark for Pathological Lymph Node Metastasis in Breast Cancer Sections [21.75452517154339]
We reprocessed 1,399 whole slide images (WSIs) and labels from the Camelyon-16 and Camelyon-17 datasets.
Based on the sizes of re-annotated tumor regions, we upgraded the binary cancer screening task to a four-class task.
arXiv Detail & Related papers (2024-11-16T09:19:24Z) - Generalizing AI-driven Assessment of Immunohistochemistry across Immunostains and Cancer Types: A Universal Immunohistochemistry Analyzer [12.164507399614347]
We developed a Universal IHC (UIHC) analyzer, an AI model for interpreting IHC images regardless of tumor or IHC types.
This multi-cohort trained model outperforms conventional single-cohort models in interpreting unseen IHCs.
arXiv Detail & Related papers (2024-07-30T08:39:30Z) - ACROBAT -- a multi-stain breast cancer histological whole-slide-image
data set from routine diagnostics for computational pathology [1.6619031082709266]
The analysis of FFPE tissue sections stained with haematoxylin and eosin (H&E) orchemistry (IHC) is an essential part of the pathologic assessment of surgically resected breast cancer specimens.
This data set has the potential to enable many different avenues of computational pathology research.
arXiv Detail & Related papers (2022-11-24T14:16:36Z) - WSSS4LUAD: Grand Challenge on Weakly-supervised Tissue Semantic
Segmentation for Lung Adenocarcinoma [51.50991881342181]
This challenge includes 10,091 patch-level annotations and over 130 million labeled pixels.
First place team achieved mIoU of 0.8413 (tumor: 0.8389, stroma: 0.7931, normal: 0.8919)
arXiv Detail & Related papers (2022-04-13T15:27:05Z) - Multi-Scale Hybrid Vision Transformer for Learning Gastric Histology:
AI-Based Decision Support System for Gastric Cancer Treatment [50.89811515036067]
Gastric endoscopic screening is an effective way to decide appropriate gastric cancer (GC) treatment at an early stage, reducing GC-associated mortality rate.
We propose a practical AI system that enables five subclassifications of GC pathology, which can be directly matched to general GC treatment guidance.
arXiv Detail & Related papers (2022-02-17T08:33:52Z) - Co-Heterogeneous and Adaptive Segmentation from Multi-Source and
Multi-Phase CT Imaging Data: A Study on Pathological Liver and Lesion
Segmentation [48.504790189796836]
We present a novel segmentation strategy, co-heterogenous and adaptive segmentation (CHASe)
We propose a versatile framework that fuses appearance based semi-supervision, mask based adversarial domain adaptation, and pseudo-labeling.
CHASe can further improve pathological liver mask Dice-Sorensen coefficients by ranges of $4.2% sim 9.4%$.
arXiv Detail & Related papers (2020-05-27T06:58:39Z) - A Global Benchmark of Algorithms for Segmenting Late Gadolinium-Enhanced
Cardiac Magnetic Resonance Imaging [90.29017019187282]
" 2018 Left Atrium Challenge" using 154 3D LGE-MRIs, currently the world's largest cardiac LGE-MRI dataset.
Analyse of the submitted algorithms using technical and biological metrics was performed.
Results show the top method achieved a dice score of 93.2% and a mean surface to a surface distance of 0.7 mm.
arXiv Detail & Related papers (2020-04-26T08:49:17Z)
This list is automatically generated from the titles and abstracts of the papers in this site.
This site does not guarantee the quality of this site (including all information) and is not responsible for any consequences.